- Nachrichtendetail
-
22.02.2024 22:06:01 - dpa-AFX: *BIOMARIN Q4 REVENUES $646.2 MLN VS. $537.5 MLN LAST YEAR
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BioMarin Pharmaceutical | 924801 | NASDAQ | 84,970 | 25.06.24 22:00:42 | -0,170 | -0,20% | 84,940 | 84,970 | 85,070 | 85,140 |
